| Title |
Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival—a substudy of the MIMOSA trial
|
|---|---|
| Published in |
Cancer Immunology, Immunotherapy, June 2014
|
| DOI | 10.1007/s00262-014-1569-0 |
| Pubmed ID | |
| Authors |
Alexia Buzzonetti, Marco Fossati, Valentina Catzola, Giovanni Scambia, Andrea Fattorossi, Alessandra Battaglia |
Mendeley readers
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 26 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 5 | 19% |
| Student > Bachelor | 3 | 12% |
| Student > Master | 3 | 12% |
| Student > Ph. D. Student | 3 | 12% |
| Other | 2 | 8% |
| Other | 2 | 8% |
| Unknown | 8 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 6 | 23% |
| Biochemistry, Genetics and Molecular Biology | 3 | 12% |
| Agricultural and Biological Sciences | 3 | 12% |
| Immunology and Microbiology | 2 | 8% |
| Business, Management and Accounting | 1 | 4% |
| Other | 3 | 12% |
| Unknown | 8 | 31% |